tiprankstipranks
Trending News
More News >
Argent Biopharma Ltd (RGTLF)
OTHER OTC:RGTLF
US Market

Argent Biopharma (RGTLF) Income Statement

Compare
31 Followers

Argent Biopharma Income Statement

See RGTLF’s key income statement, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 583.45KAU$ 891.08KAU$ 3.39MAU$ 4.73M
Gross Profit
AU$ 446.32KAU$ 203.70KAU$ 1.45MAU$ 1.81M
Operating Expenses
AU$ 15.89MAU$ 18.47MAU$ 17.05MAU$ 16.07M
Depreciation and Amortization
AU$ 789.14KAU$ 1.29MAU$ 751.94KAU$ 247.69K
EBITDA
AU$ -17.00MAU$ -15.77MAU$ -20.04MAU$ -16.70M
Operating Income
AU$ -15.44MAU$ -18.26MAU$ -15.60MAU$ -14.26M
Other Income/Expenses
AU$ -2.40MAU$ 713.39KAU$ -5.53MAU$ -2.88M
Pretax Income
AU$ -17.84MAU$ -17.55MAU$ -21.13MAU$ -17.14M
Net Income
AU$ -17.84MAU$ -17.53MAU$ -20.82MAU$ -16.77M
Per Share Metrics
Basic EPS
AU$ 0.00AU$ -0.47AU$ -7.10AU$ -6.50
Diluted EPS
AU$ 0.00AU$ -0.47AU$ -7.10AU$ -6.50
Weighted Average Shares Outstanding
0.00 37.01M 2.94M 2.57M
Weighted Average Shares Outstanding (Diluted)
0.00 37.01M 2.94M 2.57M
Currency in AUD

Argent Biopharma Earnings and Revenue History